2.33
price down icon3.72%   -0.09
pre-market  Pre-mercato:  2.42   0.09   +3.86%
loading

Tempest Therapeutics Inc Azioni (TPST) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Operating Income/Loss
27.16%
-7.966
-10.94 -13.92 -10.55 -9.582
Nonoperating Income/Loss
26.32%
0.096
0.076 0.105 -0.005 0.012
Income/Loss From Continuing Operations Before Tax
27.53%
-7.87
-10.86 -13.81 -10.56 -9.57
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
27.53%
-7.87
-10.86 -13.81 -10.56 -9.57
Net Income/Loss
27.53%
-7.87
-10.86 -13.81 -10.56 -9.57
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
10.63%
3.803
3.4377 4.3643 25.81 22.55
Diluted Average Shares
10.63%
3.803
3.4377 4.3643 25.81 22.55
Basic Earnings Per Share
34.49%
-2.07
-3.16 -0.31 -0.41 -0.42
Diluted Earnings Per Share
34.49%
-2.07
-3.16 -0.31 -0.41 -0.42
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$97.99
price up icon 2.09%
$26.80
price down icon 2.01%
$98.84
price down icon 1.21%
$109.38
price up icon 0.41%
$148.43
price down icon 0.08%
biotechnology ONC
$351.27
price down icon 0.61%
Capitalizzazione:     |  Volume (24 ore):